Cargando…
An updated perspective on immunoglobulin replacement in chronic lymphocytic leukaemia in the era of targeted therapies
Chronic lymphocytic leukaemia (CLL) is a malignancy of clonally expanded antigen-switched, neoplastic, mature B cells. CLL is characterised by a variable degree of immunosuppression and secondary hypogammaglobulinemia. B-cell depleting therapies have historically been deployed with a proportion of p...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10117948/ https://www.ncbi.nlm.nih.gov/pubmed/37091176 http://dx.doi.org/10.3389/fonc.2023.1135812 |